How to buy Medigus stock | $1.73

Medigus Ltd is a medical devices business based in the US. Medigus shares (MDGS) are listed on the NASDAQ and all prices are listed in US Dollars. Medigus employs 39 staff and has a trailing 12-month revenue of around 0.00.

Medigus stock price (NASDAQ: MDGS)

Use our graph to track the performance of MDGS stocks over time.

Medigus shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$1.73
52-week range	$1.22 - $4.19
50-day moving average	$1.72
200-day moving average	$2.15
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.78

Buy Medigus shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Medigus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Medigus Ltd by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Medigus price performance over time

Historical closes compared with the close of $1.73 from 2021-05-28

1 week (2021-07-21)	N/A
1 month (2021-07-01)	-7.98%
3 months (2021-04-30)	-11.73%
6 months (2021-01-28)	N/A

1 year (2020-07-28)	N/A
2 years (2019-07-28)	N/A
3 years (2018-07-28)	N/A
5 years (2016-07-28)	N/A

Medigus financials

Revenue TTM	$531,000
Gross profit TTM	$-503,000
Return on assets TTM	-20.43%
Return on equity TTM	-39.91%
Profit margin	0%
Book value	$1.45
Market capitalisation	$40.3 million

TTM: trailing 12 months

Shorting Medigus shares

There are currently 86,761 Medigus shares held short by investors – that's known as Medigus's "short interest". This figure is 37.4% down from 138,639 last month.

There are a few different ways that this level of interest in shorting Medigus shares can be evaluated.

Medigus's "short interest ratio" (SIR)

Medigus's "short interest ratio" (SIR) is the quantity of Medigus shares currently shorted divided by the average quantity of Medigus shares traded daily (recently around 321337.03703704). Medigus's SIR currently stands at 0.27. In other words for every 100,000 Medigus shares traded daily on the market, roughly 270 shares are currently held short.

However Medigus's short interest can also be evaluated against the total number of Medigus shares, or, against the total number of tradable Medigus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medigus's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Medigus shares in existence, roughly 0 shares are currently held short) or 0.0037% of the tradable shares (for every 100,000 tradable Medigus shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medigus.

Find out more about how you can short Medigus stock.

Medigus share dividends

We're not expecting Medigus to pay a dividend over the next 12 months.

Have Medigus's shares ever split?

Medigus's shares were split on a 1:4 basis on 15 July 2018. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Medigus shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Medigus shares which in turn could have impacted Medigus's share price.

Medigus share price volatility

Over the last 12 months, Medigus's shares have ranged in value from as little as $1.22 up to $4.19. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medigus's is 2.4472. This would suggest that Medigus's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Medigus overview

Medigus Ltd. , a medical device company, develops, produces, and markets minimally invasive endo-surgical tools with direct visualization technology in the United States, the United Kingdom, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; develops and commercializes online and offline event planning software, as well as ticketing solutions; and operates online stores for the sale of various consumer products on the Amazon online marketplace. The company was incorporated in 1999 and is headquartered in Omer, Israel. .

Frequently asked questions

What percentage of Medigus is owned by insiders or institutions?
Currently 1.874% of Medigus shares are held by insiders and 3.185% by institutions. How many people work for Medigus?
Latest data suggests 39 work at Medigus. When does the fiscal year end for Medigus?
Medigus's fiscal year ends in December. Where is Medigus based?
Medigus's address is: No. 7A, Omer Industrial Park, Omer, Israel, 8496500 What is Medigus's ISIN number?
Medigus's international securities identification number is: US58471G3002 What is Medigus's CUSIP number?
Medigus's Committee on Uniform Securities Identification Procedures number is: 58471G102